Utz Brands, Inc. (UTZ) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the thirteen and twenty-six weeks ended June 30, 2024. Utz Brands, Inc. is a leading U.S. manufacturer of branded salty snacks, operating 8 primary manufacturing facilities and distributing through approximately 2,350 direct-store delivery routes. The company is currently executing a strategy to divest "better-for-you" brands and optimize its manufacturing footprint.
Key Financial Metrics (26 Weeks Ended June 30, 2024)
| Metric | Value (in millions) |
|---|---|
| Net Sales | $702.7 |
| Gross Profit | $244.3 |
| Gross Margin | 34.8% |
| Income from Operations | $32.2 |
| Net Income (Total) | $27.8 |
| Net Income (Controlling Interest) | $15.9 |
| Adjusted EBITDA | $93.1 |
| Cash and Cash Equivalents | $66.6 |
| Total Debt (Long-term + Current) | $809.6 |
| ABL Availability | $130.3 |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 1.6% year-over-year to $702.7 million. This decline was driven by the divestiture of the Good Health and R.W. Garcia brands (2.8% impact) and continued Independent Operator (IO) conversions (0.3% impact), partially offset by favorable volume/mix (1.6%).
- Profitability: Gross margin expanded to 34.8% from 31.1% in the prior year, driven by productivity initiatives and favorable mix, despite supply chain inflation. Operating income surged to $32.2 million from $0.6 million, largely due to a $44.0 million gain on the sale of the Good Health and R.W. Garcia business.
- Expenses: Selling, distribution, and administrative expenses decreased 2.9% to $214.0 million, primarily due to the absence of $9.5 million in asset impairment and severance costs recorded in the prior year related to the Birmingham facility closure.
- Debt: Total debt decreased significantly due to $141.0 million in accelerated payments on Term Loan B and $17.7 million on the Real Estate Term Loan, funded by divestiture proceeds.
Guidance, Outlook, and Risks
- Divestitures: The company completed the sale of Good Health and R.W. Garcia brands for $167.5 million and manufacturing facilities in Berlin, PA, and Fitchburg, MA for $18.5 million. Transition services and co-manufacturing agreements with the buyer (Our Home) are in place through mid-2025.
- Cost Management: Management continues to focus on cost-saving initiatives, supply chain optimization, and pricing actions to offset commodity and labor inflation. Commodity costs have stabilized compared to 2022 but remain a monitoring point.
- Interest Rate Exposure: The company has $736.4 million in variable-rate indebtedness. While interest rates remain elevated, the company has reduced its exposure through debt paydowns and maintains interest rate swaps covering $582.9 million of debt.
- Risks: Key risks include commodity price volatility, rising labor and freight costs, competitive market dynamics, and the execution of the IO conversion strategy which impacts reported sales and gross profit.
Investor Verification Checklist
- Verify the sustainability of the 34.8% gross margin given ongoing supply chain inflation and the impact of IO conversions on net sales.
- Confirm the timeline and financial impact of the transition services agreements with "Our Home" following the divestitures.
- Monitor the company's ability to maintain debt covenant compliance as variable interest rates fluctuate.
- Assess the long-term impact of the shift from Route Sales Professionals (RSP) to Independent Operators (IO) on the company's cost structure and reported revenue.
- Review the valuation allowance on deferred tax assets, which was recorded due to cumulative losses and uncertainty regarding future utilization.